Name: Global Dolutegravir Market Insights and Forecast to 2035
Brand: Extent Research
Price: 3500 USD
Availability: InStock
Rating: 4.6 (238 reviews)

Global Dolutegravir Market

Market Size in USD Billion

CAGR : 17.60%

USD 1.14

2025

USD 4.17

2033

Forecast Period	2025 - 2033
Market Size (Base Year)	USD 1.14 Billion
Market Size (Forecast)	USD 4.17 Billion
CAGR	17.60%
Major Market Players	Data provided in full report

Global Dolutegravir Market 2026 will provide you with the in-depth competitive analysis about the Dolutegravir market which will include data for all the important parameters such as market dynamics, market segmentation, and company profiles of all the industry players operating in the Dolutegravir Market. The market dynamics will include information about the market size, value in terms of USD Million/Billion, market share, drivers, limitations, opportunities, and challenges. The report also consists of the impact of COVID-19 on the Dolutegravir market on the global platform.

Data provided by Extent Research. Source: https://www.extentresearch.com/dolutegravir-market

The global Dolutegravir market report published by the Extent Research is an extensive research study which is professionally conducted by our research analysts including all the parameters that has or will have impact on the Dolutegravir market in the coming years. The major market segments that are included in the report are by Application Prevent HIV Infection Following Potential Exposure, Other, , by Product type 10mg Tablets, 50mg Tablets, . Moreover, the key focus on the product and the applications of the Dolutegravir market have all been included in the research study. In terms of regions, this report offers the data of the production, apparent consumption, export and import of Dolutegravir market in regions and countries such as North America, Europe, China, Japan, Southeast Asia and India.

The major competitive players that are included for the Dolutegravir market in the report are ViiV Healthcare (GSK), Shanghai Desano Pharmaceuticals, Mylan, Aurobindo Pharma, LAURUS Labs, Adcock Ingram Limited, . The report also offers insights about the key strategies that the market players are currently using to tackle with the pandemic situation. In addition, all the manufacturers and suppliers that are involved in the Dolutegravir market are profiled in the report.

The information within the report is categorized into timelines: historic timeline (2015 to 2024); base year (2025), forecast period (2026-2035). With the help of primary and secondary research all the data for the Dolutegravir market is collected and is further validated with the help of top market tools. All the expert opinions and the research analysts’ observations are included in the last section: Conclusion and Observations. This report will enable the clients to better understand the market in all aspects.

Report Scope and Market Segmentation

ATTRIBUTES	Global Dolutegravir Market KEY MARKET INSIGHTS
Segments Covered	By Product Type: All Products Type Includes By Application: All Application Type Includes By End User: All End User Type Includes By Distribution Channel: All Distribution Channel Includes
Countries Covered	North America U.S., Canada, Mexico Europe Germany, United Kingdom, France, Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe Asia-Pacific China, India, Japan, New Zealand, South Korea, Australia, Southeast Asia, Rest of Asia Pacific Latin America Brazil, Argentina, Rest of Latin America Middle East & Africa Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa
Key Market Players	Leading Tier 1 Corporations Prominent Regional Manufacturers Emerging Market Disruptors Technology Integrators & Suppliers *Complete vendor layout of 15+ major players provided in the final report.
Market Opportunities	Market Size and Growth: Quantifying the total addressable market (TAM) and projected growth rates to assess financial viability. Customer Segmentation: Identifying target audience behaviors, pain points, and specific unfulfilled demands. Competitive Landscape: Analyzing existing competitors' strengths, weaknesses, and market share to pinpoint gaps and opportunities. Industry Trends: Mapping technological, regulatory, and economic shifts that create favorable conditions for market entry. Risk Assessment: Evaluating barriers to entry and operational challenges alongside strategic roadmaps for mitigation.
Value Added Data Infosets	In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by our expert team also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Meet the Team

Julie

Author

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly...

Priya M

Reviewed By

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives...

Learn more about Priya M

BASIC ATTRIBUTES \| KEY MARKET INSIGHTS
Report Title	Global Dolutegravir Market
Base Year	2025
Forecast Period	2025 - 2033
Market Size (Base)	USD 1.14 Billion
Projected Size	USD 4.17 Billion
CAGR	17.60%

                            1 Study Coverage
    1.1 Dolutegravir Product Introduction
    1.2 Market by Type
        1.2.1 Global Dolutegravir Market Size Growth Rate by Type, 2017 VS 2021 VS 2035
        1.2.2 10mg Tablets
        1.2.3 50mg Tablets
    1.3 Market by Application
        1.3.1 Global Dolutegravir Market Size Growth Rate by Application, 2017 VS 2021 VS 2035
        1.3.2 Prevent HIV Infection Following Potential Exposure
        1.3.3 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Dolutegravir Sales Estimates and Forecasts 2017-2035
    2.2 Global Dolutegravir Revenue Estimates and Forecasts 2017-2035
    2.3 Global Dolutegravir Revenue by Region: 2017 VS 2021 VS 2035
    2.4 Global Dolutegravir Sales by Region
        2.4.1 Global Dolutegravir Sales by Region (2017-2022)
        2.4.2 Global Sales Dolutegravir by Region (2023-2035)
    2.5 Global Dolutegravir Revenue by Region
        2.5.1 Global Dolutegravir Revenue by Region (2017-2022)
        2.5.2 Global Dolutegravir Revenue by Region (2023-2035)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Dolutegravir Sales by Manufacturers
        3.1.1 Global Top Dolutegravir Manufacturers by Sales (2017-2022)
        3.1.2 Global Dolutegravir Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Dolutegravir in 2021
    3.2 Global Dolutegravir Revenue by Manufacturers
        3.2.1 Global Dolutegravir Revenue by Manufacturers (2017-2022)
        3.2.2 Global Dolutegravir Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Dolutegravir Revenue in 2021
    3.3 Global Dolutegravir Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Dolutegravir Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Dolutegravir Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Dolutegravir Sales by Type
        4.1.1 Global Dolutegravir Historical Sales by Type (2017-2022)
        4.1.2 Global Dolutegravir Forecasted Sales by Type (2023-2035)
        4.1.3 Global Dolutegravir Sales Market Share by Type (2017-2035)
    4.2 Global Dolutegravir Revenue by Type
        4.2.1 Global Dolutegravir Historical Revenue by Type (2017-2022)
        4.2.2 Global Dolutegravir Forecasted Revenue by Type (2023-2035)
        4.2.3 Global Dolutegravir Revenue Market Share by Type (2017-2035)
    4.3 Global Dolutegravir Price by Type
        4.3.1 Global Dolutegravir Price by Type (2017-2022)
        4.3.2 Global Dolutegravir Price Forecast by Type (2023-2035)
5 Market Size by Application
    5.1 Global Dolutegravir Sales by Application
        5.1.1 Global Dolutegravir Historical Sales by Application (2017-2022)
        5.1.2 Global Dolutegravir Forecasted Sales by Application (2023-2035)
        5.1.3 Global Dolutegravir Sales Market Share by Application (2017-2035)
    5.2 Global Dolutegravir Revenue by Application
        5.2.1 Global Dolutegravir Historical Revenue by Application (2017-2022)
        5.2.2 Global Dolutegravir Forecasted Revenue by Application (2023-2035)
        5.2.3 Global Dolutegravir Revenue Market Share by Application (2017-2035)
    5.3 Global Dolutegravir Price by Application
        5.3.1 Global Dolutegravir Price by Application (2017-2022)
        5.3.2 Global Dolutegravir Price Forecast by Application (2023-2035)
6 North America
    6.1 North America Dolutegravir Market Size by Type
        6.1.1 North America Dolutegravir Sales by Type (2017-2035)
        6.1.2 North America Dolutegravir Revenue by Type (2017-2035)
    6.2 North America Dolutegravir Market Size by Application
        6.2.1 North America Dolutegravir Sales by Application (2017-2035)
        6.2.2 North America Dolutegravir Revenue by Application (2017-2035)
    6.3 North America Dolutegravir Market Size by Country
        6.3.1 North America Dolutegravir Sales by Country (2017-2035)
        6.3.2 North America Dolutegravir Revenue by Country (2017-2035)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Dolutegravir Market Size by Type
        7.1.1 Europe Dolutegravir Sales by Type (2017-2035)
        7.1.2 Europe Dolutegravir Revenue by Type (2017-2035)
    7.2 Europe Dolutegravir Market Size by Application
        7.2.1 Europe Dolutegravir Sales by Application (2017-2035)
        7.2.2 Europe Dolutegravir Revenue by Application (2017-2035)
    7.3 Europe Dolutegravir Market Size by Country
        7.3.1 Europe Dolutegravir Sales by Country (2017-2035)
        7.3.2 Europe Dolutegravir Revenue by Country (2017-2035)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Dolutegravir Market Size by Type
        8.1.1 Asia Pacific Dolutegravir Sales by Type (2017-2035)
        8.1.2 Asia Pacific Dolutegravir Revenue by Type (2017-2035)
    8.2 Asia Pacific Dolutegravir Market Size by Application
        8.2.1 Asia Pacific Dolutegravir Sales by Application (2017-2035)
        8.2.2 Asia Pacific Dolutegravir Revenue by Application (2017-2035)
    8.3 Asia Pacific Dolutegravir Market Size by Region
        8.3.1 Asia Pacific Dolutegravir Sales by Region (2017-2035)
        8.3.2 Asia Pacific Dolutegravir Revenue by Region (2017-2035)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Dolutegravir Market Size by Type
        9.1.1 Latin America Dolutegravir Sales by Type (2017-2035)
        9.1.2 Latin America Dolutegravir Revenue by Type (2017-2035)
    9.2 Latin America Dolutegravir Market Size by Application
        9.2.1 Latin America Dolutegravir Sales by Application (2017-2035)
        9.2.2 Latin America Dolutegravir Revenue by Application (2017-2035)
    9.3 Latin America Dolutegravir Market Size by Country
        9.3.1 Latin America Dolutegravir Sales by Country (2017-2035)
        9.3.2 Latin America Dolutegravir Revenue by Country (2017-2035)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Dolutegravir Market Size by Type
        10.1.1 Middle East and Africa Dolutegravir Sales by Type (2017-2035)
        10.1.2 Middle East and Africa Dolutegravir Revenue by Type (2017-2035)
    10.2 Middle East and Africa Dolutegravir Market Size by Application
        10.2.1 Middle East and Africa Dolutegravir Sales by Application (2017-2035)
        10.2.2 Middle East and Africa Dolutegravir Revenue by Application (2017-2035)
    10.3 Middle East and Africa Dolutegravir Market Size by Country
        10.3.1 Middle East and Africa Dolutegravir Sales by Country (2017-2035)
        10.3.2 Middle East and Africa Dolutegravir Revenue by Country (2017-2035)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 ViiV Healthcare (GSK)
        11.1.1 ViiV Healthcare (GSK) Corporation Information
        11.1.2 ViiV Healthcare (GSK) Overview
        11.1.3 ViiV Healthcare (GSK) Dolutegravir Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 ViiV Healthcare (GSK) Dolutegravir Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 ViiV Healthcare (GSK) Recent Developments
    11.2 Shanghai Desano Pharmaceuticals
        11.2.1 Shanghai Desano Pharmaceuticals Corporation Information
        11.2.2 Shanghai Desano Pharmaceuticals Overview
        11.2.3 Shanghai Desano Pharmaceuticals Dolutegravir Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Shanghai Desano Pharmaceuticals Dolutegravir Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Shanghai Desano Pharmaceuticals Recent Developments
    11.3 Mylan
        11.3.1 Mylan Corporation Information
        11.3.2 Mylan Overview
        11.3.3 Mylan Dolutegravir Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Mylan Dolutegravir Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Mylan Recent Developments
    11.4 Aurobindo Pharma
        11.4.1 Aurobindo Pharma Corporation Information
        11.4.2 Aurobindo Pharma Overview
        11.4.3 Aurobindo Pharma Dolutegravir Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Aurobindo Pharma Dolutegravir Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Aurobindo Pharma Recent Developments
    11.5 LAURUS Labs
        11.5.1 LAURUS Labs Corporation Information
        11.5.2 LAURUS Labs Overview
        11.5.3 LAURUS Labs Dolutegravir Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 LAURUS Labs Dolutegravir Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 LAURUS Labs Recent Developments
    11.6 Adcock Ingram Limited
        11.6.1 Adcock Ingram Limited Corporation Information
        11.6.2 Adcock Ingram Limited Overview
        11.6.3 Adcock Ingram Limited Dolutegravir Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Adcock Ingram Limited Dolutegravir Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Adcock Ingram Limited Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Dolutegravir Industry Chain Analysis
    12.2 Dolutegravir Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Dolutegravir Production Mode & Process
    12.4 Dolutegravir Sales and Marketing
        12.4.1 Dolutegravir Sales Channels
        12.4.2 Dolutegravir Distributors
    12.5 Dolutegravir Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Dolutegravir Industry Trends
    13.2 Dolutegravir Market Drivers
    13.3 Dolutegravir Market Challenges
    13.4 Dolutegravir Market Restraints
14 Key Findings in The Global Dolutegravir Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer                        

Research Methodology

Data collection and base year analysis are done using proprietary data collection modules with large sample sizes. The process includes obtaining market information through extensive secondary sources, paid databases, and verifying data via primary (industry expert) validation.

Our market models include Vendor Positioning Grids, Market Timeline Analysis, Company Market Share Analysis, and Top-Down/Bottom-Up forecasting models. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Speak to Analyst

Global Dolutegravir Market